Clinical Study
Investigation of the Effects of Curcumin on Serum Cytokines in Obese Individuals: A Randomized Controlled Trial
Table 1
Effect of curcumin on serum cytokine concentrations.
| | Study group | | Period | Period effect | Carryover effect | Treatment effect | 1 | 2 | Baseline | Endpoint | Baseline | Endpoint |
| IL-1α (pg/mL) | Curcumin-placebo | 15 | | | | | 0.23 | 0.27 | 0.58 | Placebo-curcumin | 15 | | | | | | IL-1β (pg/mL) | Curcumin-placebo | 15 | | | | | 0.31 | 0.13 | 0.042 | Placebo-curcumin | 15 | | | | | | IL-2 (pg/mL) | Curcumin-placebo | 15 | | | | | 0.52 | 0.84 | 0.22 | Placebo-curcumin | 15 | | | | | | IL-4 (pg/mL) | Curcumin-placebo | 15 | | | | | 0.86 | 0.01 | 0.008 | Placebo-curcumin | 15 | | | | | | IL-6 (pg/mL) | Curcumin-placebo | 15 | | | | | 0.32 | 0.65 | 0.76 | Placebo-curcumin | 15 | | | | | | IL-8 (pg/mL) | Curcumin-placebo | 15 | | | | | 0.08 | 0.40 | 0.69 | Placebo-curcumin | 15 | | | | | | IL-10 (pg/mL) | Curcumin-placebo | 15 | | | | | 0.51 | 0.10 | 0.82 | Placebo-curcumin | 15 | | | | | | IFNγ (pg/mL) | Curcumin-placebo | 15 | | | | | 0.92 | 0.47 | 0.63 | Placebo-curcumin | 15 | | | | | | EGF (pg/mL) | Curcumin-placebo | 15 | | | | | 0.14 | 0.42 | 0.73 | Placebo-curcumin | 15 | | | | | | VEGF (pg/mL) | Curcumin-placebo | 15 | | | | | 0.01 | 0.40 | 0.03 | Placebo-curcumin | 15 | | | | | | MCP-1 (pg/mL) | Curcumin-placebo | 15 | | | | | 0.09 | 0.35 | 0.54 | Placebo-curcumin | 15 | | | | | | TNFα (pg/mL) | Curcumin-placebo | 15 | | | | | 0.64 | 0.33 | 0.42 | Placebo-curcumin | 15 | | 0 | | | |
|
|
Values are expressed as mean ± SD. IL: interleukin; EGF: epidermal growth factor; VEGF: vascular endothelial growth factor; MCP-1: macrophage chemoattractant protein 1; TNF: tumor necrosis factor .
|